» Articles » PMID: 34905385

Uveal Melanoma-associated Mutations in PLCβ4 Are Constitutively Activating and Promote Melanocyte Proliferation and Tumorigenesis

Overview
Journal Sci Signal
Date 2021 Dec 14
PMID 34905385
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Activating mutations in Gα proteins are frequent in uveal melanoma, the most common eye cancer arising from the uveal tract. A small proportion of uveal melanomas have a D630Y mutation in phospholipase C β4 (PLCβ4), an effector of Gα. Here, we found that the D630Y mutation in PLCβ4 results in a high level of constitutive PLCβ4 activity. Mutations at the corresponding position in other PLC isoforms also resulted in constitutive activity, revealing an unrecognized mechanism underlying PLC activation. In cultured human uveal melanoma cell lines, inhibition of PLC suppressed proliferation in Gα-dependent cells. Furthermore, we found that PLCβ4(D630Y) mediated proliferation in cutaneous melanocytes and the growth of melanomas in mice. These results are consistent with PLCβ4(D630Y) driving oncogenic signaling downstream of Gα.

Citing Articles

Genetic Features of Uveal Melanoma.

Sorrentino F, Culiersi C, Florido A, De Nadai K, Adamo G, Nasini F Genes (Basel). 2024; 15(11).

PMID: 39596556 PMC: 11593461. DOI: 10.3390/genes15111356.


Recent Advances in Molecular and Genetic Research on Uveal Melanoma.

Fuentes-Rodriguez A, Mitchell A, Guerin S, Landreville S Cells. 2024; 13(12.

PMID: 38920653 PMC: 11201764. DOI: 10.3390/cells13121023.


Biophysical characterization of the CXC chemokine receptor 2 ligands.

Martin P, Kurth E, Budean D, Momplaisir N, Qu E, Simien J PLoS One. 2024; 19(4):e0298418.

PMID: 38625857 PMC: 11020491. DOI: 10.1371/journal.pone.0298418.


The mechanism of regulation of -catalyzed hydrolysis.

Falzone M, MacKinnon R Proc Natl Acad Sci U S A. 2023; 120(48):e2315011120.

PMID: 37991948 PMC: 10691244. DOI: 10.1073/pnas.2315011120.


MITF deficiency accelerates GNAQ-driven uveal melanoma.

Phelps G, Hagen H, Amsterdam A, Lees J Proc Natl Acad Sci U S A. 2022; 119(19):e2107006119.

PMID: 35512098 PMC: 9172632. DOI: 10.1073/pnas.2107006119.


References
1.
KIM U, Fink Jr D, Kim H, Park D, Contreras M, Guroff G . Nerve growth factor stimulates phosphorylation of phospholipase C-gamma in PC12 cells. J Biol Chem. 1991; 266(3):1359-62. View

2.
Everett K, Bunney T, Yoon Y, Rodrigues-Lima F, Harris R, Driscoll P . Characterization of phospholipase C gamma enzymes with gain-of-function mutations. J Biol Chem. 2009; 284(34):23083-93. PMC: 2755714. DOI: 10.1074/jbc.M109.019265. View

3.
KELLEY G, Reks S, Ondrako J, Smrcka A . Phospholipase C(epsilon): a novel Ras effector. EMBO J. 2001; 20(4):743-54. PMC: 145421. DOI: 10.1093/emboj/20.4.743. View

4.
Huang W, Hicks S, Sondek J, Zhang Q . A fluorogenic, small molecule reporter for mammalian phospholipase C isozymes. ACS Chem Biol. 2010; 6(3):223-8. PMC: 3312000. DOI: 10.1021/cb100308n. View

5.
Johansson P, Aoude L, Wadt K, Glasson W, Warrier S, Hewitt A . Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget. 2015; 7(4):4624-31. PMC: 4826231. DOI: 10.18632/oncotarget.6614. View